Anaplastic Lymphoma Kinase Mutation–Positive Non–Small Cell Lung Cancer
Author:
Publisher
Elsevier BV
Subject
Pulmonary and Respiratory Medicine,Surgery
Reference67 articles.
1. ALK resistance mutations and efficacy of lorlatinib in advanced anaplastic lymphoma kinase-positive non-small-cell lung cancer;Shaw;J Clin Oncol,2019
2. Natural history and factors associated with overall survival in stage IV ALK-rearranged non-small cell lung cancer;Pacheco;J Thorac Oncol,2019
3. ALK in Non-Small Cell Lung Cancer (NSCLC) pathobiology, epidemiology, detection from tumor tissue and algorithm diagnosis in a daily practice;Hofman;Cancers (Basel),2017
4. Genetic alterations defining NSCLC subtypes and their therapeutic implications;Pikor;Lung Cancer,2013
5. Crizotinib versus chemotherapy in advanced ALK-positive lung cancer;Shaw;N Engl J Med,2013
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The prognostic relationship of 18F-FDG PET/CT metabolic and volumetric parameters in metastatic ALK + NSCLC;Nuclear Medicine Communications;2022-10-19
2. Alectinib rescue therapy in advanced ALK rearranged lung adenocarcinoma: a case report;Monaldi Archives for Chest Disease;2022-09-20
3. The Change in Paradigm for NSCLC Patients with EML4–ALK Translocation;International Journal of Molecular Sciences;2022-06-30
4. Commentary: Using the entire toolbox for improved survival in anaplastic lymphoma kinase–positive non–small cell lung cancer: The next normal?;The Journal of Thoracic and Cardiovascular Surgery;2022-02
5. A Comprehensive Analysis of Metabolomics and Transcriptomics Reveals Novel Biomarkers and Mechanistic Insights on Lorlatinib Crosses the Blood-Brain Barrier;Frontiers in Pharmacology;2021-08-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3